Cargando…

Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial

BACKGROUND AND AIMS: Probiotics, prebiotics and synbiotics have been suggested as dietary strategies to improve intestinal barrier function. This study aimed to assess the effect of two weeks synbiotic supplementation on intestinal permeability under basal and stressed conditions. Secondary aims wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilms, E., Gerritsen, J., Smidt, H., Besseling-van der Vaart, I., Rijkers, G. T., Garcia Fuentes, A. R., Masclee, A. A. M., Troost, F. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147956/
https://www.ncbi.nlm.nih.gov/pubmed/27936169
http://dx.doi.org/10.1371/journal.pone.0167775
_version_ 1782473769100509184
author Wilms, E.
Gerritsen, J.
Smidt, H.
Besseling-van der Vaart, I.
Rijkers, G. T.
Garcia Fuentes, A. R.
Masclee, A. A. M.
Troost, F. J.
author_facet Wilms, E.
Gerritsen, J.
Smidt, H.
Besseling-van der Vaart, I.
Rijkers, G. T.
Garcia Fuentes, A. R.
Masclee, A. A. M.
Troost, F. J.
author_sort Wilms, E.
collection PubMed
description BACKGROUND AND AIMS: Probiotics, prebiotics and synbiotics have been suggested as dietary strategies to improve intestinal barrier function. This study aimed to assess the effect of two weeks synbiotic supplementation on intestinal permeability under basal and stressed conditions. Secondary aims were the assessment of two weeks synbiotic supplementation on systemic immune function and gastrointestinal symptoms including defecation pattern. DESIGN: Twenty healthy adults completed a double-blind, controlled, randomized, parallel design study. INTERVENTION: Groups either received synbiotic (1.5 × 10(10) CFU Ecologic(®) 825 + 10 g fructo-oligosaccharides (FOS P6) per day) or control supplements for two weeks. OUTCOMES: Intestinal segment specific permeability was assessed non-invasively by oral administration of multiple sugar probes and, subsequently, assessing the excretion of these probes in urine. This test was conducted at baseline and at the end of intervention, in the absence and in the presence of an indomethacin challenge. Indomethacin was applied to induce a compromised gut state. Plasma zonulin, cytokines and chemokines were measured at baseline and at the end of intervention. Gastrointestinal symptoms and stool frequency were recorded at baseline and daily during intervention. RESULTS: Significantly more male subjects were in the synbiotic group compared to the control group (P = 0.025). Indomethacin significantly increased urinary lactulose/rhamnose ratio versus without indomethacin, both in the control group (P = 0.005) and in the synbiotic group (P = 0.017). Urinary sugar recoveries and ratios, plasma levels of zonulin, cytokines and chemokines, and gastrointestinal symptom scores were not significantly different after control or synbiotic intervention. Stool frequency within the synbiotic group was significantly increased during synbiotic intervention compared to baseline (P = 0.039) and higher compared to control intervention (P = 0.045). CONCLUSION: Two weeks Ecologic(®) 825/FOS P6 supplementation increased stool frequency, but did not affect intestinal permeability neither under basal nor under indomethacin-induced stressed conditions, immune function or gastrointestinal symptoms in healthy adults.
format Online
Article
Text
id pubmed-5147956
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51479562016-12-28 Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial Wilms, E. Gerritsen, J. Smidt, H. Besseling-van der Vaart, I. Rijkers, G. T. Garcia Fuentes, A. R. Masclee, A. A. M. Troost, F. J. PLoS One Research Article BACKGROUND AND AIMS: Probiotics, prebiotics and synbiotics have been suggested as dietary strategies to improve intestinal barrier function. This study aimed to assess the effect of two weeks synbiotic supplementation on intestinal permeability under basal and stressed conditions. Secondary aims were the assessment of two weeks synbiotic supplementation on systemic immune function and gastrointestinal symptoms including defecation pattern. DESIGN: Twenty healthy adults completed a double-blind, controlled, randomized, parallel design study. INTERVENTION: Groups either received synbiotic (1.5 × 10(10) CFU Ecologic(®) 825 + 10 g fructo-oligosaccharides (FOS P6) per day) or control supplements for two weeks. OUTCOMES: Intestinal segment specific permeability was assessed non-invasively by oral administration of multiple sugar probes and, subsequently, assessing the excretion of these probes in urine. This test was conducted at baseline and at the end of intervention, in the absence and in the presence of an indomethacin challenge. Indomethacin was applied to induce a compromised gut state. Plasma zonulin, cytokines and chemokines were measured at baseline and at the end of intervention. Gastrointestinal symptoms and stool frequency were recorded at baseline and daily during intervention. RESULTS: Significantly more male subjects were in the synbiotic group compared to the control group (P = 0.025). Indomethacin significantly increased urinary lactulose/rhamnose ratio versus without indomethacin, both in the control group (P = 0.005) and in the synbiotic group (P = 0.017). Urinary sugar recoveries and ratios, plasma levels of zonulin, cytokines and chemokines, and gastrointestinal symptom scores were not significantly different after control or synbiotic intervention. Stool frequency within the synbiotic group was significantly increased during synbiotic intervention compared to baseline (P = 0.039) and higher compared to control intervention (P = 0.045). CONCLUSION: Two weeks Ecologic(®) 825/FOS P6 supplementation increased stool frequency, but did not affect intestinal permeability neither under basal nor under indomethacin-induced stressed conditions, immune function or gastrointestinal symptoms in healthy adults. Public Library of Science 2016-12-09 /pmc/articles/PMC5147956/ /pubmed/27936169 http://dx.doi.org/10.1371/journal.pone.0167775 Text en © 2016 Wilms et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Wilms, E.
Gerritsen, J.
Smidt, H.
Besseling-van der Vaart, I.
Rijkers, G. T.
Garcia Fuentes, A. R.
Masclee, A. A. M.
Troost, F. J.
Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title_full Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title_fullStr Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title_full_unstemmed Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title_short Effects of Supplementation of the Synbiotic Ecologic(®) 825/FOS P6 on Intestinal Barrier Function in Healthy Humans: A Randomized Controlled Trial
title_sort effects of supplementation of the synbiotic ecologic(®) 825/fos p6 on intestinal barrier function in healthy humans: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147956/
https://www.ncbi.nlm.nih.gov/pubmed/27936169
http://dx.doi.org/10.1371/journal.pone.0167775
work_keys_str_mv AT wilmse effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT gerritsenj effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT smidth effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT besselingvandervaarti effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT rijkersgt effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT garciafuentesar effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT mascleeaam effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial
AT troostfj effectsofsupplementationofthesynbioticecologic825fosp6onintestinalbarrierfunctioninhealthyhumansarandomizedcontrolledtrial